About WINOBOLIC Cooper Pharma
WINOBOLIC Cooper Pharma is a stanozolol-based research compound classified as a synthetic anabolic-androgenic steroid derived from dihydrotestosterone. This oral formulation enables researchers to investigate androgenic receptor binding mechanisms and anabolic pathway modulation in laboratory settings. Stanozolol demonstrates unique pharmacological properties, including reduced androgenic activity relative to its anabolic effects in preclinical models. Research facilities studying steroid biochemistry often examine this compound’s molecular interactions with androgen receptors and its effects on protein synthesis pathways. The Cooper Pharma formulation provides standardised dosing for reproducible experimental protocols in academic and pharmaceutical research environments.
Laboratory Applications
Researchers at Stroid UK Shop utilise stanozolol preparations to study anabolic steroid mechanisms in various experimental models. This compound proves valuable for investigating androgenic receptor selectivity, examining differences between anabolic and androgenic tissue responses, and analysing hepatic metabolism pathways in controlled laboratory conditions. Scientists studying performance-enhancing drug detection methods frequently include stanozolol in their analytical protocols due to its distinctive metabolic profile. Additionally, researchers examining cardiovascular effects of anabolic steroids incorporate this compound into comparative studies alongside other stanozolol research preparations. The oral bioavailability characteristics make it suitable for investigating first-pass hepatic metabolism and drug interaction studies. Many research institutions combine stanozolol investigations with studies of selective androgen receptor modulators to compare tissue-selective androgenic effects.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Stanozolol |
| CAS Registry | 10418-03-8 |
| Molecular Formula | C₂₁H₃₂N₂O |
| Molecular Weight | 328.49 g/mol |
| Form | Oral tablets |
| Manufacturer | Cooper Pharma |
| Storage Requirements | Room temperature, dry environment |
| Research Classification | Anabolic-androgenic steroid |
Laboratories studying metabolic pathways often examine stanozolol alongside research peptides to understand different mechanisms of anabolic signalling in experimental models.
Research Compliance
WINOBOLIC Cooper Pharma is supplied exclusively for in-vitro laboratory research and analytical testing purposes. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure compliance with institutional guidelines and applicable regulations when conducting studies with anabolic steroid compounds. Proper laboratory safety protocols, including appropriate containment and waste disposal procedures, must be followed during all experimental procedures involving this research material.
